ESOPAug 11, 2026, 04:03 PM
BridgeBio Grants 66,705 RSUs to 56 New Employees
AI Summary
BridgeBio Pharma, Inc. announced that its compensation committee approved equity grants to 56 new employees. These grants consist of restricted stock units totaling 66,705 shares of the company's common stock. The awards are intended as an inducement for the employees to join the company, with a vesting schedule beginning August 16, 2027, and continuing quarterly thereafter.
Key Highlights
- Equity grants approved for 56 new employees.
- Total of 66,705 restricted stock units (RSUs) granted.
- One-fourth of shares underlying each RSU will vest on August 16, 2027.
- One-twelfth of remaining shares vest quarterly thereafter.
- Awards granted as an inducement for employment.
Price Impact
More from BBIO